Immunohistochemistry-Based Screening for Targetable Kinase Alterations in Non-Langerhans Cell Histiocytosis with Juvenile Xanthogranuloma morphology
Virchows Archiv · 13.04.2026
DOI: 10.1007/s00428-026-04523-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Virchows Archiv, online erschienen am 13.04.2026. Verfasst von Kenichi Sakamoto und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan. sakamoto-k@shinshu-u.ac.jp. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Juvenile xanthogranuloma (JXG) has historically been defined as a morphologic entity within non-Langerhans cell histiocytosis. Recent studies have demonstrated that a subset of histiocytic lesions with JXG morphology harbor targetable kinase alterations, including ALK and NTRK rearrangements, particularly in systemic or extracutaneous disease. We evaluated an immunohistochemistry (IHC)-based screening strategy for detecting targetable kinase alterations in histiocytic lesions with JXG morphology. IHC screening for ALK and pan-TRK was performed, followed by confirmatory fluorescence in situ hybridization (FISH) and next-generation sequencing (NGS) when feasible.We evaluated an immunohistochemistry (IHC)-based screening strategy for detecting targetable kinase alterations in histiocytic lesions with JXG morphology. IHC screening for ALK and pan-TRK, and BRAF V600E was performed, followed by confirmatory fluorescence in situ hybridization (FISH) and targeted next-generation sequencing (NGS) when feasible. Six of 28 patients (21%) were positive on IHC (ALK, n = 4; pan-TRK, n = 2), all of whom had systemic disease, representing 46% of systemic cases. All IHC-positive cases were confirmed by FISH. Targeted NGS identified fusion genes in analyzable cases, including KIF5B::ALK and TPM3::NTRK1, with RNA-based sequencing being limited by specimen quality in some cases, while DNA-based comprehensive genomic profiling showed higher feasibility in recently processed samples. These findings demonstrate that IHC-based screening followed by confirmatory FISH provides a rapid and cost-effective strategy for identifying cases of non-LCH with JXG morphology harboring actionable kinase alterations. Integration of IHC, FISH, and NGS represents a practical and complementary diagnostic strategy to guide precision therapy in this clinically diverse histiocytic disorder.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan. sakamoto-k@shinshu-u.ac.jp.
- Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan. sakamoto-k@shinshu-u.ac.jp.
- Department of Pediatrics, Hirosaki University School of Medicine, Hirosaki, Japan.
- Department of Pathology, National Center for Child Health and Development, Tokyo, Japan.
- Department of Pediatrics, Jichi Medical University School of Medicine, Shimotsuke, Japan.
- Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan.
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Sakamoto, K., Ko, K., Yoshioka, T., Morimoto, A., Shioda, Y., & Nakazawa, A. (2026). Immunohistochemistry-Based Screening for Targetable Kinase Alterations in Non-Langerhans Cell Histiocytosis with Juvenile Xanthogranuloma morphology. Virchows Archiv. https://doi.org/10.1007/s00428-026-04523-0
Vancouver
Sakamoto K, Ko K, Yoshioka T, Morimoto A, Shioda Y, Nakazawa A. Immunohistochemistry-Based Screening for Targetable Kinase Alterations in Non-Langerhans Cell Histiocytosis with Juvenile Xanthogranuloma morphology. Virchows Archiv. 2026. doi:10.1007/s00428-026-04523-0
BibTeX
@article{Sakamoto2026,
author = {Sakamoto, Kenichi and Ko, Kudo and Yoshioka, Takako and Morimoto, Akira and Shioda, Yoko and Nakazawa, Atsuko},
title = {Immunohistochemistry-Based Screening for Targetable Kinase Alterations in Non-Langerhans Cell Histiocytosis with Juvenile Xanthogranuloma morphology},
journal = {Virchows Archiv},
year = {2026},
doi = {10.1007/s00428-026-04523-0}
}
EUVIMED